Park Ha Biological Technology is trading 8.23% up at $3.20 in pre-market trading, with no clear company-specific catalyst identified for August 21, 2026.
- An August 19 investor-law-firm solicitation concerned a pending securities lawsuit.
- Earlier reporting highlighted the August 6 reverse split; neither development was explicitly linked to the gain.
- Broader index futures are modestly higher, but thin-stock volatility and trading activity appear to be driving the move.